HLS Therapeutics Inc (HLS.TO)
3.66
+0.06
(+1.67%)
CAD |
TSX |
Sep 27, 16:00
HLS Therapeutics Shareholders Equity (Quarterly): 113.24M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 113.24M |
March 31, 2024 | 120.59M |
December 31, 2023 | 129.56M |
September 30, 2023 | 138.33M |
June 30, 2023 | 147.65M |
March 31, 2023 | 160.76M |
December 31, 2022 | 170.01M |
September 30, 2022 | 179.75M |
June 30, 2022 | 186.03M |
March 31, 2022 | 198.50M |
December 31, 2021 | 204.85M |
September 30, 2021 | 210.05M |
June 30, 2021 | 210.52M |
March 31, 2021 | 211.35M |
December 31, 2020 | 215.80M |
September 30, 2020 | 225.98M |
June 30, 2020 | 230.22M |
March 31, 2020 | 240.32M |
December 31, 2019 | 232.74M |
September 30, 2019 | 249.54M |
June 30, 2019 | 252.81M |
March 31, 2019 | 209.49M |
December 31, 2018 | 215.89M |
September 30, 2018 | 215.51M |
June 30, 2018 | 244.60M |
Date | Value |
---|---|
March 31, 2018 | 244.91M |
December 31, 2017 | 226.74M |
September 30, 2017 | 32.56M |
June 30, 2017 | 32.85M |
March 31, 2017 | 33.20M |
December 31, 2016 | 33.66M |
September 30, 2016 | 34.04M |
June 30, 2016 | 34.32M |
March 31, 2016 | 34.80M |
December 31, 2015 | 36.10M |
September 30, 2015 | 36.79M |
June 30, 2015 | 52.28M |
March 31, 2015 | 52.61M |
December 31, 2014 | 54.26M |
September 30, 2014 | 48.16M |
June 30, 2014 | 45.59M |
March 31, 2014 | 45.18M |
December 31, 2013 | 43.14M |
September 30, 2013 | 42.57M |
June 30, 2013 | 41.92M |
March 31, 2013 | 43.14M |
December 31, 2012 | 40.76M |
September 30, 2012 | 41.47M |
June 30, 2012 | 39.86M |
March 31, 2012 | 35.77M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
113.24M
Minimum
Jun 2024
249.54M
Maximum
Sep 2019
188.79M
Average
201.68M
Median
Shareholders Equity (Quarterly) Benchmarks
DRI Healthcare Trust | 525.26M |
Biocure Technology Inc | 1.559M |
Core One Labs Inc | 5.641M |
Nova Mentis Life Science Corp | -1.046M |
Nanosphere Health Sciences Inc | -2.231M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 261.96M |
Total Liabilities (Quarterly) | 148.72M |
Debt to Equity Ratio | 0.9968 |
Current Ratio | 2.024 |
Net Debt Paydown Yield | 2.76% |